Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Joshua Petit

Concepts (101)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Radiosurgery
7
2022
398
0.800
Why?
Brachytherapy
3
2017
132
0.520
Why?
Androgen Antagonists
2
2008
91
0.500
Why?
Prostatic Neoplasms
3
2008
972
0.460
Why?
Trigeminal Neuralgia
3
2004
15
0.300
Why?
Goserelin
1
2008
8
0.270
Why?
Tosyl Compounds
1
2008
17
0.270
Why?
Nelson Syndrome
1
2007
5
0.270
Why?
Dysuria
1
2007
3
0.270
Why?
Leuprolide
1
2008
21
0.260
Why?
Pituitary ACTH Hypersecretion
1
2007
12
0.260
Why?
Proton Therapy
1
2007
16
0.260
Why?
Acromegaly
1
2007
17
0.260
Why?
Anilides
1
2008
83
0.260
Why?
Nitriles
1
2008
212
0.240
Why?
Prostate
1
2007
159
0.240
Why?
Antineoplastic Agents, Hormonal
1
2008
196
0.240
Why?
Prostate-Specific Antigen
1
2006
162
0.230
Why?
Neoplasm Recurrence, Local
1
2006
1160
0.150
Why?
Radiation Oncology
1
2020
83
0.140
Why?
Near Miss, Healthcare
1
2018
12
0.140
Why?
Papillomavirus Infections
1
2022
345
0.140
Why?
Dermatology
1
2020
131
0.130
Why?
Risk Management
1
2018
81
0.130
Why?
Patient Safety
2
2018
352
0.130
Why?
Head and Neck Neoplasms
1
2022
563
0.130
Why?
Health Plan Implementation
1
2018
143
0.130
Why?
Safety Management
1
2018
130
0.130
Why?
Medical Errors
1
2018
124
0.130
Why?
46, XX Disorders of Sex Development
1
2016
7
0.120
Why?
Mullerian Ducts
1
2016
16
0.120
Why?
Adenocarcinoma, Papillary
1
2016
11
0.120
Why?
Gallbladder Neoplasms
1
2016
20
0.120
Why?
Radiotherapy
1
2017
209
0.120
Why?
Carcinoma, Squamous Cell
1
2020
628
0.110
Why?
Hospitals
1
2018
738
0.100
Why?
Aged, 80 and over
6
2008
8391
0.090
Why?
Neoadjuvant Therapy
2
2022
475
0.090
Why?
Magnetic Resonance Imaging
3
2007
3926
0.080
Why?
Middle Aged
8
2008
36619
0.070
Why?
Aged
7
2008
26432
0.070
Why?
Bromocriptine
1
2007
31
0.070
Why?
Growth Hormone-Secreting Pituitary Adenoma
1
2007
12
0.070
Why?
Octreotide
1
2007
23
0.070
Why?
Urinary Catheterization
1
2007
35
0.060
Why?
Growth Hormone
1
2007
91
0.060
Why?
Protons
1
2007
96
0.060
Why?
Remission Induction
1
2007
308
0.060
Why?
Morbidity
1
2008
319
0.060
Why?
Adult
8
2016
41087
0.060
Why?
Humans
15
2022
146342
0.060
Why?
Male
9
2008
73396
0.060
Why?
Massachusetts
1
2006
178
0.060
Why?
Adenoma
1
2007
210
0.060
Why?
Hydrocortisone
1
2007
303
0.060
Why?
Insulin-Like Growth Factor I
1
2007
320
0.060
Why?
Kaplan-Meier Estimate
1
2007
970
0.050
Why?
Risk
1
2007
920
0.050
Why?
Combined Modality Therapy
1
2008
1271
0.050
Why?
Brain Stem
1
2004
101
0.050
Why?
Survival Analysis
1
2006
1378
0.050
Why?
Treatment Outcome
3
2007
11821
0.040
Why?
Apoptosis Regulatory Proteins
1
2002
186
0.040
Why?
Glioma
2
2004
425
0.040
Why?
Female
8
2017
79499
0.040
Why?
Membrane Glycoproteins
1
2002
495
0.040
Why?
Follow-Up Studies
2
2006
5439
0.040
Why?
Postoperative Period
1
2020
355
0.040
Why?
Adolescent
2
2007
22557
0.030
Why?
Pain
1
2003
790
0.030
Why?
Tumor Necrosis Factor-alpha
1
2002
1224
0.030
Why?
Quality of Life
3
2004
3200
0.030
Why?
Radiotherapy Planning, Computer-Assisted
1
2017
150
0.030
Why?
Congenital Abnormalities
1
2016
108
0.030
Why?
Cohort Studies
1
2006
6077
0.030
Why?
Antibodies, Monoclonal
1
2022
1512
0.030
Why?
Skin
1
2020
701
0.030
Why?
Brain Neoplasms
1
2004
1325
0.030
Why?
Medical Oncology
1
2017
345
0.030
Why?
Apoptosis
1
2002
2439
0.020
Why?
Patient Selection
1
2017
728
0.020
Why?
Societies, Medical
1
2017
907
0.020
Why?
Risk Factors
1
2006
10921
0.020
Why?
United States
2
2020
16136
0.020
Why?
Skin Neoplasms
1
2017
806
0.020
Why?
Quality Improvement
1
2018
1354
0.020
Why?
Retrospective Studies
1
2007
17438
0.020
Why?
Trigeminal Nerve Diseases
1
2004
3
0.010
Why?
Hypesthesia
1
2004
21
0.010
Why?
Nerve Compression Syndromes
1
2004
23
0.010
Why?
Breast Neoplasms
1
2017
2418
0.010
Why?
Radiotherapy Dosage
1
2004
289
0.010
Why?
TNF-Related Apoptosis-Inducing Ligand
1
2002
54
0.010
Why?
Receptors, Tumor Necrosis Factor
1
2002
162
0.010
Why?
Neoplasms
1
2017
2954
0.010
Why?
Cell Death
1
2002
379
0.010
Why?
Recurrence
1
2004
1133
0.010
Why?
Survivors
1
2004
526
0.010
Why?
Survival Rate
1
2004
2092
0.010
Why?
Gene Expression Regulation, Neoplastic
1
2002
1432
0.010
Why?
Cell Line, Tumor
1
2002
3545
0.010
Why?
Petit's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)